Literature DB >> 34963063

Association of entorhinal cortical tau deposition and hippocampal synaptic density in older individuals with normal cognition and early Alzheimer's disease.

Adam P Mecca1, Ming-Kai Chen2, Ryan S O'Dell3, Mika Naganawa2, Takuya Toyonaga2, Tyler A Godek3, Joanna E Harris3, Hugh H Bartlett3, Wenzhen Zhao3, Emmie R Banks3, Gessica S Ni3, Kelly Rogers3, Jean Dominique Gallezot2, Jim Ropchan2, Paul R Emery2, Nabeel B Nabulsi2, Brent C Vander Wyk4, Amy F T Arnsten5, Yiyun Huang2, Richard E Carson2, Christopher H van Dyck6.   

Abstract

Sites of early neuropathologic change provide important clues regarding the initial clinical features of Alzheimer's disease (AD). We have shown significant reductions in hippocampal synaptic density in participants with AD, consistent with the early degeneration of entorhinal cortical (ERC) cells that project to hippocampus via the perforant path. In this study, [11C]UCB-J binding to synaptic vesicle glycoprotein 2A (SV2A) and [18F]flortaucipir binding to tau were measured via PET in 10 participants with AD (5 mild cognitive impairment, 5 mild dementia) and 10 cognitively normal participants. In the overall sample, ERC tau was inversely associated with hippocampal synaptic density (r = -0.59, p = 0.009). After correction for partial volume effects, the association of ERC tau with hippocampal synaptic density was stronger in the overall sample (r = -0.61, p = 0.007) and in the AD group where the effect size was large, but not statistically significant (r = -0.58, p = 0.06). This inverse association of ERC tau and hippocampal synaptic density may reflect synaptic failure due to tau pathology in ERC neurons projecting to the hippocampus.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Alzheimer's disease; PET; SV2A; Synaptic density; Tau; [(11)C]UCB-J; [(18)F]Flortaucipir

Mesh:

Substances:

Year:  2021        PMID: 34963063      PMCID: PMC8761170          DOI: 10.1016/j.neurobiolaging.2021.11.004

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  46 in total

1.  Topographic organization of cortical inputs to the lateral nucleus of the macaque monkey amygdala: a retrograde tracing study.

Authors:  L Stefanacci; D G Amaral
Journal:  J Comp Neurol       Date:  2000-05-22       Impact factor: 3.215

2.  Neurofibrillary pathology leads to synaptic loss and not the other way around in Alzheimer disease.

Authors:  Khalid Iqbal; Inge Grundke-Iqbal
Journal:  J Alzheimers Dis       Date:  2002-06       Impact factor: 4.472

3.  Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.

Authors:  Heiko Braak; Dietmar R Thal; Estifanos Ghebremedhin; Kelly Del Tredici
Journal:  J Neuropathol Exp Neurol       Date:  2011-11       Impact factor: 3.685

4.  A comparison of five partial volume correction methods for Tau and Amyloid PET imaging with [18F]THK5351 and [11C]PIB.

Authors:  Miho Shidahara; Benjamin A Thomas; Nobuyuki Okamura; Masanobu Ibaraki; Keisuke Matsubara; Senri Oyama; Yoichi Ishikawa; Shoichi Watanuki; Ren Iwata; Shozo Furumoto; Manabu Tashiro; Kazuhiko Yanai; Kohsuke Gonda; Hiroshi Watabe
Journal:  Ann Nucl Med       Date:  2017-06-21       Impact factor: 2.668

5.  Kinetic evaluation and test-retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans.

Authors:  Sjoerd J Finnema; Nabeel B Nabulsi; Joël Mercier; Shu-Fei Lin; Ming-Kai Chen; David Matuskey; Jean-Dominique Gallezot; Shannan Henry; Jonas Hannestad; Yiyun Huang; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-09       Impact factor: 6.200

6.  Brain contains two forms of synaptic vesicle protein 2.

Authors:  S M Bajjalieh; K Peterson; M Linial; R H Scheller
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

7.  Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9.

Authors:  Thierry Bussière; Panteleimon Giannakopoulos; Constantin Bouras; Daniel P Perl; John H Morrison; Patrick R Hof
Journal:  J Comp Neurol       Date:  2003-08-25       Impact factor: 3.215

Review 8.  Tau-mediated synaptic damage in Alzheimer's disease.

Authors:  Santosh Jadhav; Veronika Cubinkova; Ivana Zimova; Veronika Brezovakova; Aladar Madari; Viera Cigankova; Norbert Zilka
Journal:  Transl Neurosci       Date:  2015-10-23       Impact factor: 1.757

9.  Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.

Authors:  Michael J Pontecorvo; Michael D Devous; Michael Navitsky; Ming Lu; Stephen Salloway; Frederick W Schaerf; Danna Jennings; Anupa K Arora; Anne McGeehan; Nathaniel C Lim; Hui Xiong; Abhinay D Joshi; Andrew Siderowf; Mark A Mintun
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

10.  In vivo tau pathology is associated with synaptic loss and altered synaptic function.

Authors:  Emma M Coomans; Deborah N Schoonhoven; Hayel Tuncel; Sander C J Verfaillie; Emma E Wolters; Ronald Boellaard; Rik Ossenkoppele; Anouk den Braber; Wiep Scheper; Patrick Schober; Steven P Sweeney; J Michael Ryan; Robert C Schuit; Albert D Windhorst; Frederik Barkhof; Philip Scheltens; Sandeep S V Golla; Arjan Hillebrand; Alida A Gouw; Bart N M van Berckel
Journal:  Alzheimers Res Ther       Date:  2021-02-05       Impact factor: 6.982

View more
  1 in total

Review 1.  Synaptic Vesicle Glycoprotein 2A: Features and Functions.

Authors:  Rachele Rossi; Shokouh Arjmand; Simone Larsen Bærentzen; Albert Gjedde; Anne M Landau
Journal:  Front Neurosci       Date:  2022-04-28       Impact factor: 5.152

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.